|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Provision (credit) for credit losses | |||||
| Depreciation and amortization of premises and equipment | |||||
| Loss on disposal of premises and equipment | |||||
| Non-cash lease expense (benefit) | |||||
| Cash flows from operating leases | |||||
| Amortization of mortgage servicing rights | |||||
| Net amortization of premium (accretion of discount) on investment securities | |||||
| Share-based compensation | |||||
| Net loss (gain) on sales of investment securities | |||||
| Net gain on sales of residential mortgage loans | |||||
| Proceeds from sales of loans held for sale | |||||
| Origination of loans held for sale | |||||
| Equity in (earnings) losses of unconsolidated entities | |||||
| Distributions from unconsolidated entities | |||||
| Net increase in cash surrender value of bank-owned life insurance | |||||
| Deferred income tax expense | |||||
| Net tax benefit from share-based compensation | |||||
| Amortization and impairment of intangible assets | |||||
| Net change in other assets and liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of investment securities available-for-sale | |||||
| Proceeds from maturities, prepayments and calls of investment securities available-for-sale | |||||
| Proceeds from sales of investment securities available-for-sale | |||||
| Purchases of held-to-maturity investment securities | |||||
| Proceeds from maturities, prepayments and calls of investment securities held-to-maturity | |||||
| Loan payments (originations), net | |||||
| Purchases of loan portfolios | |||||
| Proceeds from sales of loans originated for investment | |||||
| Purchases of bank-owned life insurance | |||||
| Proceeds from bank-owned life insurance death benefits | |||||
| Net purchases of premises, equipment and land | |||||
| Proceeds from sales of premises, equipment and land | |||||
| Net return of capital from unconsolidated entities | |||||
| Contributions to unconsolidated entities | |||||
| Net proceeds from (purchases) redemption of FRB and FHLB stock | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Net (decrease) increase in deposits | |||||
| Net decrease in FHLB advances and other short-term borrowings | |||||
| Proceeds from long-term debt | |||||
| Repayments of long-term debt | |||||
| Cash dividends paid on common stock | |||||
| Repurchases of common stock and other related costs | |||||
| Net proceeds from issuance of common stock and stock option exercises | |||||
| Net cash (used in) provided by financing activities | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid during the year for: | |||||
| Interest expense paid | |||||
| Income taxes (received) paid, net | |||||
| Supplemental non-cash disclosures: | |||||
| Net change in common stock held by directors' deferred compensation plan | |||||
| Net transfer of portfolio loans to loans held for sale | |||||
| Net transfer of investment securities from available-for-sale to held-to-maturity at fair value | |||||
| Lease liabilities arising from obtaining right-of-use lease assets | |||||
| Amortization of unrealized losses on investment securities transferred to held-to-maturity at fair value | |||||
| Other intangible assets and services provided in exchange for Swell common stock | |||||
| Other intangible assets received in exchange for Swell common stock | |||||
Loading...
